Click here to return to our homepage

  

 

  

 

 

    

 

 

 

 

Search Articles

Top of Form

Select Year:
Search Term:

Bottom of Form

 

 


RN Village

 

 

Careers

 

 


Job Search

Upcoming Career Fairs

Previous Career Fairs

Resume Builder

Career Advice

Facility Profiles

Salary Wizard

Relocation Tool

Career Assessment
Tool


Nursing Careers

Spotlight On

Travel

 

 

Education

 

 


Education
Marketplace


Nursing Schools

RN Resources

CE Log Book

Clinical Library

Featured CE

Employer-Sponsored CE

Educational Seminars
and Events

 

 

News

 

 


Web Exclusives

Archives

Daily Headlines

Editor's Note

Question of the Week

Readers Forum

5 Minutes With

Industry Pulse

Good Question

E-Talk

First Person

Help Wanted

 



 

 

 

PR Newswire

Home

Help

 

 

 

 

 

 

 

Healthcare/Medical News

Back to Headlines

ImageStream(R) Used for Pioneering Advance in AIDS Research

    SEATTLE, July 25 /PRNewswire/ -- Amnis Corporation, a manufacturer of

advanced instrumentation for the life science research and diagnostics

markets, announced today the publication of a major new study in the field

of AIDS research. The pioneering work, involving the development of a

robust murine model for long-term KSHV infection, was carried out by Dr.

Dean Kedes and colleagues at the University of Virginia Health System.

KSHV, a gamma herpesvirus, is the etiologic agent of Kaposi's sarcoma, the

most common AIDS-associated malignancy worldwide.

    "The establishment of this mouse model for KSHV infection provides a

valuable tool that will enable us to achieve a better understanding of

longitudinal patterns of viral gene expression, cell tropism and immune

responses," said Dr. Kedes, a member of the University's Myles H. Thaler

Center for AIDS and Retrovirus Research. "We believe that this new

information will help in furthering our ability to understand how this

virus causes tumors and, in the future, to design better ways of preventing

or treating them." The lead author of the paper describing the work, Dr.

Christopher Parsons, is also of the University of Virginia Health System.

    "We are extremely gratified that the ImageStream system was employed

for this important research," said David Basiji, Ph.D., Amnis' President

and CEO. "Since its inception, we have been confident that ImageStream

technology would ultimately have a direct impact on human health. The

ImageStream system allowed Dr. Kedes and his colleagues to identify rare

splenocyte subpopulations containing the virus and quantitate their numbers

and level of infection with high specificity and sensitivity."

    This research has been the subject of a previous announcement by the

University of Virginia, which may be found at

http://www.newswise.com/articles/view/521478/.

    Amnis Corporation, headquartered in Seattle, WA, develops, manufactures

and markets instrumentation for high speed imaging of cells in flow. Its

flagship product, the ImageStream cell analysis system, generates six high

resolution microscopic images of cells as they flow through the instrument

at rates up to 300 cells per second. The system is unique in its ability to

image tens of thousands of cells in minutes without the need to make

slides. The IDEAS(R) image analysis package, an integral part of the

ImageStream system, is a highly sophisticated yet easy to use tool for

processing hundreds of thousands of images at a time. IDEAS enables highly

advanced research applications in hematology, immunology, oncology and

provides a critical foundation for the company's clinical applications

development.

 

 

 

News Headlines from:
PR Newswire - United Business Media

 

 

 

 

 

HomeSubscriptionsContact UsPrivacy PolicyCE Accreditation

NurseWeek Publishing, Inc. 2002
All Rights Reserved